Recent Blogs

Finding, Treating, and Curing Rare Diseases

By Ashish Patel | November 29, 2021

Picture the following scenario: A patient presents with symptoms including numbness, tremors, and occasional weakness, among others. Genetic testing exists to check for rare cardiovascular diseases and defects, but it is expensive and not currently listed as part of the diagnosis protocol. Because of this, his doctors didn’t order the test. He suffered from these…

Read More

Transparency in Specialty Pharmacy Supply Chains

By Ashish Patel | November 9, 2021

Navigating the world of Specialty Pharmacy is complex and riddled with information asymmetry.  But, it just got a lot easier. CareSet provides the experience and unblocked data to connect your new medication with the Specialty Pharmacies and prescribing physicians you need to reach your target patient populations. Characterizing the industry, the co-founder and former president…

Read More

Unblocking Part D, MarketView 

By Ashish Patel | October 19, 2021

In specialty pharmacies, some medications may have partially blocked data. Manufacturers, payers, and specialty pharmacies can elect to block this data. When they do, it’s no longer visible to their allied and competitive healthcare stakeholders, like yourself.  CareSet’s Part D Targeting product provides brand teams clarity using Medicare’s unblocked claims data. This allows us to…

Read More

Do doctors force their patients to use fax? A CareSet Journal FOIA Whitepaper

By Alma Trotter | August 18, 2021

Introduction Do patients benefit from the money that the U.S. Government has spent on the interoperability of clinical systems? The Centers for Medicare and Medicaid Services (CMS) believes that the purpose of the $34 billion dollar Electronic Health Record (EHR) Incentive Programs (aka “Meaningful Use”), is to provide patients with access to their medical records…

Read More

Updated HOP Teaming Dataset Released During PMSA 2021

By Brian Lang | June 18, 2021

The HOP Teaming Dataset from CareSet offers the most detailed and up-to-date picture of the patient-sharing relationships found between all U.S. Medicare providers HOUSTON – CareSet released the updated HOP Teaming Dataset during the Pharmaceutical Management Science Association (PMSA) 2021 Annual Conference. The release is a game-changing dataset that offers the most detailed and up-to-date…

Read More

CareSet gets accelerated access to Medicare data to perform COVID data analysis

By Brian Lang | June 11, 2021

CareSet is proud to announce that we are now the FIRST (that we know of) company with access to fee-for-service claims data (Part A, B & D), refreshed monthly, and with an industry best 2-week lag.  CareSet is using this data to perform analysis of the ongoing COVID pandemic, and how it impacts Medicare patients…

Read More

Transparency victories regarding facility-level COVID data

By Fred Trotter | May 21, 2021

HHS has recently released data about vaccinated personnel at different hospitals. They have also released a new “master key” that helps to identify how hospitals are being enumerated as part of the COVID reporting system. Both of these new data resources have been made public as part of the collaboration that CareSet and other data…

Read More

NPI to contact domain data release

By Alma Trotter | April 20, 2021

CareSet Journal is releasing data that links NPI records to the contact domains submitted by providers in their NPI applications. For example, when Jane Smith applied for an NPI, she provided a contact email of “jane.smith@examplehospital.com”. In this data, her NPI will be listed alongside the domain of “examplehospital.com”. If you want to dive straight…

Read More

I got the COVID-19 vaccine and this is what happened

By Victoria Hernandez | March 3, 2021

I am a Mexicana, and I participated in one of the SARS-CoV-2 vaccine trials! Unfortunately, I was a placebo arm. Now, I’m fully vaccinated! This is my experience after receiving both injections.  There have been efforts by the FDA to increase the participation of historically underrepresented groups in clinical trials. Kaiser Health News discussed how…

Read More

Finally Unblinded from the COVID-19 Vaccine Trial

By Victoria Hernandez | February 19, 2021

September 2020, I made the decision to participate in one of the SARS-CoV-2 vaccine trials. There is still vaccine hesitancy. My participation in this trial, along with my blog posts, are all in hopes of increasing transparency, and building trust within the trial community. You can follow my journey beginning with my first blog.  When…

Read More